Dow Jones

38,686.32

1.51%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Abraxis Bioscience Inc. (MM) (ABII)
Abraxis Bioscience Inc. (MM) (ABII) Noticias

ABII

Abraxis Bioscience Inc. (MM) (ABII)

Abraxis Bioscience Inc. (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ABII

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
15/10/2010	12:03	Edgar (US Regulatory)	(25-NSE)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
13/10/2010	15:30	Business Wire	Celgene and Abraxis Announce Shareholder Vote in Favor of Merger	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
12/10/2010	06:01	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
06/10/2010	05:03	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
14/09/2010	16:24	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
10/09/2010	16:24	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (PRER14A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
05/08/2010	15:56	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
29/07/2010	10:29	Dow Jones News	2nd UPDATE: Celgene 2Q Profit Up 8.8%; Again Boosts 2010 View	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
29/07/2010	08:45	Dow Jones News	UPDATE: Celgene 2Q Profit Up 8.8%; Again Increases 2010 View	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
29/07/2010	06:28	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
29/07/2010	04:00	Business Wire	Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
23/07/2010	08:00	Business Wire	ABRAXANE® Approved for Marketing in Japan for Breast Cancer	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
19/07/2010	15:16	Business Wire	Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Abraxis BioScience Inc.	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
12/07/2010	16:27	Business Wire	Faruqi & Faruqi, LLP Investigates Potential Breaches of Fiduciary Duties by the Board of Abraxis BioSciences, Inc. - ABII	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
09/07/2010	15:37	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
08/07/2010	16:30	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
07/07/2010	18:41	Business Wire	The Law Office of Joseph Klein Investigates Possible Breach of Fiduciary Duty by the Board of Abraxis BioSciences Inc. - ABII	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
02/07/2010	15:29	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
02/07/2010	10:36	Business Wire	Wolf Haldenstein Investigates Abraxis Bioscience, Inc. Proposed Acquisition	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
01/07/2010	16:24	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	20:30	Business Wire	Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Abraxis BioScience, Inc.	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	19:05	Business Wire	Robbins Umeda LLP Announces an Investigation of the Acquisition of Abraxis BioScience Inc. by Celgene Corporation	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	17:16	Business Wire	Finkelstein Thompson LLP Announces Investigation of Abraxis Bioscience Inc.	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	15:30	Business Wire	Ryan & Maniskas, LLP Announces Investigation of Abraxis BioScience, Inc.	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	14:57	Dow Jones News	3rd UPDATE:Celgene Buy Of Abraxis Expands Cancer Treatment Push	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	14:30	Dow Jones News	Abraxis Deal Value Depends On CVRs; CVRs Seen Undervalued	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	13:54	Business Wire	Tripp Levy PLLC Investigates Buyout of Abraxis BioSciences	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	12:14	Dow Jones News	2nd UPDATE:Celgene Buy Of Abraxis Expands Cancer Treatment Push	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	12:01	Business Wire	Kendall Law Group Investigates Abraxis BioScience Inc. Merger for Shareholders	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)
30/06/2010	12:00	Business Wire	Goldfarb Branham Law Firm LLP Investigating Potentially Unfair Buyout of Abraxis	NASDAQ:ABII	Abraxis Bioscience Inc. (MM)